Erik Jensen

Nov 18, 2024 | jamanetwork.com | Erik Jensen

Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia: Balancing Risk and Reward Bronchopulmonary dysplasia (BPD) is a severe chronic respiratory illness that develops in over half of infants born extremely premature.1 BPD predisposes affected infants to earlier mortality and deficits in cardiopulmonary health, neurodevelopment, and quality of life that can persist through childhood and into adulthood.1 Systemic corticosteroids are one of the few drugs shown in randomized clinical...

Nov 4, 2024 | nature.com | Timothy D. Nelin |Erik Jensen

AbstractTo examine the association of novel furosemide versus thiazide diuretic exposure with changes in serum sodium, potassium, and chloride levels among infants with grade 2/3 bronchopulmonary dysplasia (BPD). Retrospective cohort study of infants admitted to a level IV neonatal intensive care unit (NICU) with grade 2/3 BPD.

May 20, 2024 | mdpi.com | Jonathan Szeto |Joshua Radack |Sara B. DeMauro |Erik Jensen

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.